JP2009517009A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009517009A5 JP2009517009A5 JP2008541750A JP2008541750A JP2009517009A5 JP 2009517009 A5 JP2009517009 A5 JP 2009517009A5 JP 2008541750 A JP2008541750 A JP 2008541750A JP 2008541750 A JP2008541750 A JP 2008541750A JP 2009517009 A5 JP2009517009 A5 JP 2009517009A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- group
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05111262 | 2005-11-24 | ||
| EP05111265 | 2005-11-24 | ||
| US75370605P | 2005-12-22 | 2005-12-22 | |
| US75366805P | 2005-12-22 | 2005-12-22 | |
| PCT/EP2006/068859 WO2007060213A2 (en) | 2005-11-24 | 2006-11-23 | Erythropoietin polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009517009A JP2009517009A (ja) | 2009-04-30 |
| JP2009517009A5 true JP2009517009A5 (https=) | 2010-02-04 |
Family
ID=37807876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541750A Pending JP2009517009A (ja) | 2005-11-24 | 2006-11-23 | エリスロポエチンポリペプチド及びそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080260746A1 (https=) |
| EP (1) | EP1966237A2 (https=) |
| JP (1) | JP2009517009A (https=) |
| AU (1) | AU2006316450A1 (https=) |
| CA (1) | CA2621705A1 (https=) |
| IL (1) | IL191426A (https=) |
| WO (1) | WO2007060213A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1715479A4 (en) * | 2004-02-09 | 2008-09-03 | Pioneer Design Corp | OPTICAL ELEMENT, OPTICAL BUYER AND INFORMATION RECORDING / REPRODUCING DEVICE |
| US7625564B2 (en) | 2006-01-27 | 2009-12-01 | Novagen Holding Corporation | Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| WO2008074851A2 (en) * | 2006-12-19 | 2008-06-26 | Nokad | Method for inhibiting the expression of endogenous erythropoietin (epo) |
| WO2008151841A2 (en) * | 2007-06-15 | 2008-12-18 | University Of Zurich | Treatment for alzheimer' s disease |
| BRPI0814465B1 (pt) | 2007-07-26 | 2021-11-23 | Novagen Holding Corporation | Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica |
| WO2012097256A1 (en) * | 2011-01-14 | 2012-07-19 | University Of Tennessee Research Foundation | Therapeutic compositions and methods for disorders associated with neuronal degeneration |
| CN102816853A (zh) * | 2012-08-30 | 2012-12-12 | 山东百福基因科技有限公司 | 运动机能相关基因epo荧光检测试剂盒及检测方法 |
| DK2928921T3 (da) | 2012-12-05 | 2021-04-19 | Novartis Ag | Sammensætninger og fremgangsmåder til antistoffer målrettet epo |
| US20210340241A1 (en) * | 2014-06-12 | 2021-11-04 | Andremacon S.R.L. | Use of negative functional modulators of erythropoietin for therapy |
| CN107922975B (zh) | 2015-08-12 | 2022-06-28 | 诺华股份有限公司 | 治疗眼科病症的方法 |
| CN110475786A (zh) * | 2017-02-27 | 2019-11-19 | 大邱庆北科学技术院 | 红细胞生成素衍生肽通过其对预防细胞损伤的作用的用途 |
| WO2022159414A1 (en) | 2021-01-22 | 2022-07-28 | University Of Rochester | Erythropoietin for gastroinfestinal dysfunction |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4558006A (en) * | 1983-02-04 | 1985-12-10 | Kirin-Amgen, Inc. | A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin |
| NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| DE3923963A1 (de) * | 1989-07-20 | 1991-01-31 | Behringwerke Ag | Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung |
| JP4170421B2 (ja) * | 1996-08-06 | 2008-10-22 | 佳子 安田 | 増殖性臓器疾患治療・改善剤 |
| AU721196B2 (en) * | 1996-10-25 | 2000-06-29 | G.D. Searle & Co. | Circularly permuted erythropoietin receptor agonists |
| US7033774B2 (en) * | 1997-04-21 | 2006-04-25 | Glycozyme, Inc. | Determination of recombinant glycosylated proteins and peptides in biological fluids |
| US20040229779A1 (en) * | 1999-05-14 | 2004-11-18 | Ramesh Kekuda | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| US6974684B2 (en) * | 2001-08-08 | 2005-12-13 | Curagen Corporation | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| AU2002364586A1 (en) * | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| EP1552298A4 (en) * | 2002-07-01 | 2006-11-08 | Kenneth S Warren Inst Inc | RECOMBINANT TISSUE-PROOFING CYTOKINS AND NUCLEIC ACIDS COORDINATING THEREOF FOR THE PROTECTION, RECOVERY AND IMPROVEMENT OF CELLS, TISSUE AND ORGANS THEREOF |
| AU2003304034A1 (en) * | 2002-08-09 | 2004-11-01 | Curagen Corporation | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| US7846466B2 (en) * | 2004-06-10 | 2010-12-07 | Northwestern University | Biodegradable scaffolds and uses thereof |
-
2006
- 2006-11-23 WO PCT/EP2006/068859 patent/WO2007060213A2/en not_active Ceased
- 2006-11-23 JP JP2008541750A patent/JP2009517009A/ja active Pending
- 2006-11-23 US US12/094,869 patent/US20080260746A1/en not_active Abandoned
- 2006-11-23 CA CA002621705A patent/CA2621705A1/en not_active Abandoned
- 2006-11-23 EP EP06830107A patent/EP1966237A2/en not_active Withdrawn
- 2006-11-23 AU AU2006316450A patent/AU2006316450A1/en not_active Abandoned
-
2008
- 2008-05-14 IL IL191426A patent/IL191426A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2433181C2 (ru) | Рекомбинантный слитый человеческий белок epo-fc с продленным временем полужизни и повышенной эритропоэтической активностью in vivo (варианты), димерная белковая конструкция, димерный белок, фармацевтическая композиция, последовательность нуклеиновой кислоты (варианты), вектор экспрессии, клетка, способ получения белка и способ стимуляции эритропоэза у млекопитающего | |
| CN110234355B (zh) | 单体人IgG1 Fc和双特异性抗体 | |
| US20190070264A1 (en) | Interleukin 15 protein complex and use thereof | |
| CN109715658B (zh) | 可溶性成纤维细胞生长因子受体3(sfgfr3)多肽及其用途 | |
| JP2009517009A5 (https=) | ||
| JP2009517055A (ja) | ニューレグリン変異体、並びにそれをスクリーニングし、及び使用する方法 | |
| US20120083453A1 (en) | Treatment using neublastin polypeptides | |
| US20130096065A1 (en) | Neublastin variants | |
| AU2002250203B2 (en) | Use of neublastin polypeptides for treating neuropathic pain | |
| CN114667298A (zh) | Siglec-9 ecd融合分子及其使用方法 | |
| CN102603886A (zh) | 突变的成纤维细胞生长因子及在治疗内分泌疾病中的用途 | |
| US20220119448A1 (en) | Artificial recombinant protein for improving performance of active protein or polypeptide and use thereof | |
| US10308917B2 (en) | Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof | |
| JP2005519946A (ja) | 発作の処置のためのインターフェロンβ様分子 | |
| JP2009513689A5 (https=) | ||
| CN117264054B (zh) | 靶向il-6的纳米抗体、组合物、方法及用途 | |
| TW202317176A (zh) | 長效型多肽及其生產和給藥的方法 | |
| US20250075003A1 (en) | Nanoparticles comprising fusion protein of single-chain variable fragment and ferritin, and use thereof | |
| US12221488B2 (en) | APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositions and use thereofus01 | |
| RS52910B (sr) | Polimerni konjugati mutiranog neublastina | |
| WO2025029881A1 (en) | Combination therapy with a sirpa-based chimeric protein and azacitidine | |
| TW202608918A (zh) | 雙鏈構建體的配對 | |
| JP2023515825A (ja) | 血管疾患を治療するためのアンジオポエチン模倣物およびｔｉｅ２アゴニストとしての、ｃ４結合タンパク質ｃ末端セグメントとアンジオポエチン－１フィブリノゲン様ドメインとの間のキメラ融合 | |
| CN120603842A (zh) | Il-2突变体及其用途 | |
| CN120322249A (zh) | 人透明质酸酶1突变体 |